Malehmir, Mohsen
Pfister, Dominik
Gallage, Suchira
Szydlowska, Marta http://orcid.org/0000-0002-4660-899X
Inverso, Donato http://orcid.org/0000-0003-0987-3345
Kotsiliti, Elena
Leone, Valentina
Peiseler, Moritz
Surewaard, Bas G. J.
Rath, Dominik
Ali, Adnan
Wolf, Monika Julia
Drescher, Hannah
Healy, Marc E.
Dauch, Daniel
Kroy, Daniela
Krenkel, Oliver
Kohlhepp, Marlene
Engleitner, Thomas
Olkus, Alexander
Sijmonsma, Tjeerd
Volz, Julia
Deppermann, Carsten http://orcid.org/0000-0003-3740-8635
Stegner, David http://orcid.org/0000-0003-1059-9865
Helbling, Patrick http://orcid.org/0000-0001-6488-2805
Nombela-Arrieta, César http://orcid.org/0000-0003-0415-259X
Rafiei, Anahita
Hinterleitner, Martina http://orcid.org/0000-0001-7137-0541
Rall, Marcel
Baku, Florian
Borst, Oliver
Wilson, Caroline L.
Leslie, Jack
O’Connor, Tracy
Weston, Christopher J. http://orcid.org/0000-0002-9651-1264
Chauhan, Abhishek
Adams, David H.
Sheriff, Lozan
Teijeiro, Ana
Prinz, Marco
Bogeska, Ruzhica
Anstee, Natasha
Bongers, Malte N. http://orcid.org/0000-0003-2852-0270
Notohamiprodjo, Mike
Geisler, Tobias
Withers, Dominic J. http://orcid.org/0000-0002-8009-7521
Ware, Jerry http://orcid.org/0000-0001-8860-6338
Mann, Derek A.
Augustin, Hellmut G.
Vegiopoulos, Alexandros
Milsom, Michael D.
Rose, Adam J. http://orcid.org/0000-0001-9132-8244
Lalor, Patricia F.
Llovet, Josep M. http://orcid.org/0000-0003-0547-2667
Pinyol, Roser
Tacke, Frank
Rad, Roland
Matter, Matthias http://orcid.org/0000-0002-2005-5266
Djouder, Nabil
Kubes, Paul http://orcid.org/0000-0002-2835-4244
Knolle, Percy A. http://orcid.org/0000-0003-2983-0414
Unger, Kristian
Zender, Lars
Nieswandt, Bernhard
Gawaz, Meinrad http://orcid.org/0000-0003-1124-9592
Weber, Achim http://orcid.org/0000-0003-0073-3637
Heikenwalder, Mathias http://orcid.org/0000-0002-3135-2274
Article History
Received: 14 September 2017
Accepted: 28 January 2019
First Online: 1 April 2019
Change Date: 18 February 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41591-022-01693-7
Competing interests
: J.M.L. receives consulting fees from Bayer HealthCare Pharmaceuticals, Eli Lilly, Bristol-Myers Squibb, Merck, Eisai Inc, Celsion Corporation, Exelixis, Merck, Ipsen, Glycotest, Navigant, Leerink Swann LLC, Midatech Ltd, Fortress Biotech, Sprink Pharmaceuticals and Nucleix and research support from Bayer HealthCare Pharmaceuticals, Eisai Inc, Bristol-Myers Squibb and Ipsen. This article presents independent research supported in part by the National Institute for Health Research (NIHR) Birmingham Biomedical Research Centre. The views expressed are those of the author(s) and not necessarily those of the National Health Service, the NIHR, or the Department of Health.